Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

Key facts

Sponsor

Michigan State University

Principal Investigator

Natoshia R Cunningham, PhD

Michigan State University

Intervention

TEACH(behavioral)

Enrollment

175 enrolled

Eligibility

12-22 years · All sexes

Timeline

2024 – 2027

Study locations (7)

• University of Alabama Birmingham Hospital, Birmingham, Alabama, United States
• Children's Hospital of New Orleans/ Tulane University, New Orleans, Louisiana, United States
• Helen Devos Children's Hospital, Grand Rapids, Michigan, United States
• Montefiore Medical Center, The Bronx, New York, United States
• Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
• Seattle Children's Hospital, Seattle, Washington, United States
• The Hospital for Sick Children, Toronto, Ontario, Canada

Collaborators

United States Department of Defense · The Hospital for Sick Children · Seattle Children's Hospital · Children's Hospital Medical Center, Cincinnati · Tulane University · University of Alabama at Birmingham · Helen DeVos Children's Hospital · Montefiore Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Systemic lupus erythematosus

Additional recruiting or active studies for the same condition.

• RECRUITINGEARLY PHASE1NCT07107659
  Safety and Efficacy of ONT01 in Lupus
  Hospital for Special Surgery, New York
• RECRUITINGNANCT07558850
  Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
  The First Affiliated Hospital with Nanjing Medical University
• RECRUITINGNCT06948110
  Deciphering the Genetic Architecture of Autoimmune Diseases
  National Human Genome Research Institute (NHGRI)
• RECRUITINGPHASE2NCT07409181
  A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
  Boehringer Ingelheim
• RECRUITINGPHASE3NCT07332481
  A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
  EMD Serono Research & Development Institute, Inc.
• RECRUITINGEARLY PHASE1NCT07526350
  MTS109 in Patients With Refractory Autoimmune Diseases
  Shanghai Changzheng Hospital
• RECRUITINGEARLY PHASE1NCT07490041
  Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
  The Children's Hospital of Zhejiang University School of Medicine
• RECRUITINGNANCT07470151
  Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

See all trials for Systemic lupus erythematosus →